BeOne Medicines AG Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4,548	2,627	3,172	3,870	4,376
Short-Term Investments	-	-	-	665.25	2,242
Cash & Short-Term Investments	4,548	2,627	3,172	4,535	6,618
Cash Growth	73.08%	-17.16%	-30.06%	-31.47%	42.29%
Accounts Receivable	865.08	676.28	358.03	173.17	483.11
Inventory	608.23	494.99	416.12	282.35	242.63
Other Current Assets	212.75	192.92	257.47	216.75	270.5
Total Current Assets	6,234	3,992	4,203	5,207	7,614
Net Property, Plant & Equipment	1,790	1,718	1,419	955.91	705.04
Other Intangible Assets	62.7	51.1	57.14	40.62	46.68
Other Long-Term Assets	102.42	160.49	125.36	175.69	169.93
Total Assets	8,189	5,921	5,805	6,379	8,536
Accounts Payable	479.04	405	315.11	294.78	262.4
Accrued Expenses	1,109	803.71	693.73	467.35	558.06
Short-Term Debt	57.29	851.53	688.37	328.97	427.57
Current Portion of Leases	20.7	17.58	21.95	24.04	21.93
Unearned Revenue	-	-	-	213.86	187.41
Other Current Liabilities	162.68	137.08	90.96	139.52	142.2
Total Current Liabilities	1,829	2,215	1,810	1,469	1,600
Long-Term Debt	961.91	166.48	197.62	209.15	202.11
Long-Term Leases	52.94	44.28	22.25	34.52	43.04
Other Long-Term Liabilities	983.7	163.03	237.97	283.74	558.25
Total Long-Term Liabilities	1,999	373.79	457.84	527.41	803.41
Total Liabilities	3,827	2,589	2,268	1,996	2,403
Common Stock	0.14	0.14	0.14	0.14	0.13
Additional Paid-in Capital	12,759	12,088	11,599	11,541	11,191
Accumulated Other Comprehensive Income	-78.18	-148.99	-99.45	-77.42	17.95
Retained Earnings	-8,320	-8,607	-7,962	-7,080	-5,077
Shareholders' Equity	4,361	3,332	3,537	4,383	6,133
Total Liabilities & Equity	8,189	5,921	5,805	6,379	8,536
Total Debt	1,093	1,080	930.19	596.68	694.64
Net Cash (Debt)	3,455	1,548	2,242	3,938	5,923
Net Cash Growth	123.24%	-30.96%	-43.08%	-33.51%	44.86%
Net Cash Per Share	30.45	14.70	21.47	38.19	63.84
Book Value	4,361	3,332	3,537	4,383	6,133
Book Value Per Share	38.44	31.65	33.89	42.50	66.09
Tangible Book Value	4,298	3,281	3,480	4,343	6,086
Tangible Book Value Per Share	37.89	31.16	33.34	42.11	65.59

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q